18/11 2026 Interim Report Q3 – January – September, 2026 Redsense Medical AB (publ.) July – September 2026 · Net sales amounted to kSEK 7,630 (6,935). · Operating result, EBIT amounted to kSEK 1,268 (-428). · EBIT excl. exchange… [read more]
16/10 2026 Valberedning utsedd inför årsstämman 2027 i Redsense Medical AB En valberedning har etablerats inför årsstämman 2027 i Redsense Medical AB (publ). Valberedningen, som har utsetts i enlighet med de principer som antagits av årsstämman… [read more]
16/10 2026 Nomination committee appointed for the 2027 Annual General Meeting in Redsense Medical AB A nomination committee has been established ahead of the 2027 annual general meeting in Redsense Medical AB (publ). The nomination committee, which has been appointed… [read more]